These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 29063621)
1. Impetigo: A need for new therapies in a world of increasing antimicrobial resistance. D'Cunha NM; Peterson GM; Baby KE; Thomas J J Clin Pharm Ther; 2018 Feb; 43(1):150-153. PubMed ID: 29063621 [TBL] [Abstract][Full Text] [Related]
2. Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns. Williamson DA; Carter GP; Howden BP Clin Microbiol Rev; 2017 Jul; 30(3):827-860. PubMed ID: 28592405 [TBL] [Abstract][Full Text] [Related]
3. Topical Ozenoxacin Cream 1% for Impetigo: A Review. Schachner L; Andriessen A; Bhatia N; Grada A; Patele D J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625 [TBL] [Abstract][Full Text] [Related]
4. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo. Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559 [TBL] [Abstract][Full Text] [Related]
5. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. Vogel A; Lennon D; Best E; Leversha A N Z Med J; 2016 Oct; 129(1443):77-83. PubMed ID: 27736855 [TBL] [Abstract][Full Text] [Related]
6. Treating impetigo in primary care. Drug Ther Bull; 2007 Jan; 45(1):2-4. PubMed ID: 17367045 [TBL] [Abstract][Full Text] [Related]
7. Impetigo: diagnosis and treatment. Hartman-Adams H; Banvard C; Juckett G Am Fam Physician; 2014 Aug; 90(4):229-35. PubMed ID: 25250996 [TBL] [Abstract][Full Text] [Related]
8. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Impetigo in the Pediatric Population: Consensus and Future Directions. Schachner LA; Torrelo A; Grada A; Micali G; Kwong PC; Scott GB; Benjamin L; Gonzalez ME; Andriessen A; Eberlein T; Eichenfield LF J Drugs Dermatol; 2020 Mar; 19(3):281-290. PubMed ID: 32550690 [TBL] [Abstract][Full Text] [Related]
10. Formaldehyde as an alternative to antibiotics for treatment of refractory impetigo and other infectious skin diseases. Nikolic P; Mudgil P; Whitehall J Expert Rev Anti Infect Ther; 2019 Sep; 17(9):681-687. PubMed ID: 31393185 [No Abstract] [Full Text] [Related]
11. Treatment of Impetigo with Antiseptics-Replacing Antibiotics (TIARA) trial: a single blind randomised controlled trial in school health clinics within socioeconomically disadvantaged communities in New Zealand. Primhak S; Gataua A; Purvis D; Thompson JMD; Walker C; Best E; Leversha A Trials; 2022 Feb; 23(1):108. PubMed ID: 35109906 [TBL] [Abstract][Full Text] [Related]
13. A primer on topical antibiotics for the skin and eyes. Noah S J Drugs Dermatol; 2008 Apr; 7(4):409-15. PubMed ID: 18459527 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of impetigo. Cole C; Gazewood J Am Fam Physician; 2007 Mar; 75(6):859-64. PubMed ID: 17390597 [TBL] [Abstract][Full Text] [Related]
18. Current resistance patterns of Staphylococcus aureus towards topical antibiotics and relevant antiseptics in patients with atopic dermatitis and impetigo. Thum D; Seidl HP; Hein R; Ring J; Andres C; Mempel M J Dtsch Dermatol Ges; 2013 Sep; 11(9):875-8. PubMed ID: 23621472 [No Abstract] [Full Text] [Related]
19. A comparative review of current topical antibiotics for impetigo. Galindo E; Hebert AA Expert Opin Drug Saf; 2021 Jun; 20(6):677-683. PubMed ID: 33726585 [TBL] [Abstract][Full Text] [Related]
20. Bacterial resistance and impetigo treatment trends: a review. Bangert S; Levy M; Hebert AA Pediatr Dermatol; 2012; 29(3):243-8. PubMed ID: 22299710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]